Iván D Vélez MD PhD. Malaria ROL OF INVESTIGATORS  Politicians,  Health authorities  Pharmaceutical industry  Pipeline and deliver products for.

Slides:



Advertisements
Similar presentations
David M. Pollock Medical College of Georgia Discovery-Academia.
Advertisements

Education and Innovation. Business Efficiency Drivers.
INTRA REGIONAL CO-OPERATION OBJECTIVES  Promote R&D in structural chemistry and biology and chemistry – biology interface  Address issues related to.
Pharmaceuticals and Global Health Inequalities and Innovation in the 21 st Century.
Single-Patient Use of Investigational Drugs and Biologic Products for Treating Cancer Grant Williams, M.D. Medical Team Leader DODP/CDER/FDA.
Financial Conflicts of Interest in Medical Research Karen Santoro Deputy Ethics Counselor National Institute of Allergy and Infectious Diseases.
The Open Innovation Center Susie Stephens, Principal Research Scientist, Eli Lilly.
Biopharmaceutical Section of the American Statistical Association 1 Biopharmaceutical Section.
“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.
Pharmaceuticals and Global Health: Successes, Challenges and Outlook 19. July 2013, University of Sussex Thomas B. Cueni, Secretary General Interpharma.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Rianto Setiabudy Dept. of Pharmacology School of Medicine University of Indonesia Jakarta, 30 April 2015.
ICORD 2009: Facilitating Cooperation in Regulatory Efforts Timothy Cote, MD MPH Director, FDA Office of Orphan Products Development, Food and Drug Administration,
Health and Medical Science Nick Besley Manager, Marketing and Communications, Science, Engineering and Health.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 13 Technology in Medicine.
Research & Innovation Horizon societal challenge 1 Open Info Day Funding Opportunities for SMEs Horizon 2020 "Health, demographic change and wellbeing"
Thinking of Studying Biological Sciences? Dr Amrit Mudher Lecturer in Neurosciences School of Biological Sciences University of Southampton
Drug Discovery Exchange Fellowship Workshop 9 th -10 th December Mike Hardman IMI EMTRAIN Coordinator.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
05/09/2015www.ecrin.org1 European Clinical Research Infrastructures Network
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
Stefan Franzén Introduction to clinical trials.
Project Leader Authority in Pharmaceutical Discovery & Development is Inversely Proportional to Aggregate Project Risk James Samanen President James Samanen.
African medicinal plants against malaria
SARC Developmental Therapeutics Committee Update Chand Khanna Open Science: Biology to Therapy” SARC Developmental Therapeutics Committee Update Chand.
This curriculum is available on the NWABR website, Permission granted for educational use ©2012 Northwest Association for Biomedical.
1 EU-funded health research activities against TB: FP6 actions and perspectives toward FP7 DG Research - European Commission 22 MARCH 2007.
BLI Research Project By: Tiffany Hou Artemisinin.
Biomedical Research. What is Biomedical Research Biomedical research is the area of science devoted to the study of the processes of life; prevention.
Slide 1 Community Networks to Reduce Cancer Health Disparities Pre-Application Conference May 26, 2004 Bethesda, MD Kenneth C. Chu, PhD Chief, Disparities.
Developing medicines for the future and why it is challenging Angela Milne.
Managing Risk Through Pharmaceutical Product Life Cycles Hosted and Sponsored by Novartis Institutes for Biomedical Research for HBA Boston Chapter February.
ERM and the Pharmaceutical Industry. Risk  An innate part of every aspect of life, and the business environment is of no exception  Severity, both in.
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
The pharmaceutical R&D process
FDA Health Psychology. FDA = Food & Drug Administration Part of Dept of Health & __________ Services.
Miriam Evans International Niemann Pick Disease Alliance (INPDA) Contact: Tel: +44 (0) #raredisease Patient involvement.
Can we kick start the Danish health industry – and how? Sigmund Lubanski Head of Division Ministry of Business and Growth.
1 Operation of the Prescription Drug User Fee Program Janet Woodcock, M.D. Deputy Commissioner for Operations November 14, 2005.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Scott C. Denne, MD Associate Director, Indiana CTSI April 25, 2011 Plenary Session.
1 Medication Development for Treatment of Drug Dependence Donald R. Wesson, MD Consultant, CNS Medications Development Chairman, ASAM Medications Development.
In the Name of God Almighty. Investigations of IMOD TM in Management of HIV / AIDS.
ARRRR! Drug Development and Discovery Access to Essential Medicines De-Cal Fall Week 2.
Foundation Doctors’ Academic Meeting Kathryn Adcock Wellcome Trust March 2011.
A model collaboration using the Pool Susanne Hollinger, Ph.D., J.D. Chief Intellectual Property Officer Emory University.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Cannabis Stock Market The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce,
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
Innovation and the Pharmaceutical Research and Development Industry January 2002 MSD South Africa.
ANALGESIC, ANESTHETIC, AND ADDICTION CLINICAL TRIAL TRANSLATIONS, INNOVATIONS, OPPORTUNITIES, AND NETWORKS (ACTTION) Public-Private Partnership WITH.
State of the TB Alliance
October 2017.
Action: BM0806 Recent Advances in Histamine Receptor H4R Research
Gestora brasileiro focada exclusivamente na área da saúde.
סמים וסינפסות.
Non For Profit Model for Rare Disease Therapy Development
Mapping Sponsored Collaborations
الحد من المشاكل السلوكية في رياض الاطفال
Theme: Translational Research - Conversation between Clinical and Basic Scientists Group 4 !
Implementation: the Case of Egypt
Clinical and Translational Science Scholars Program
Trial Funding and Engagement: The NIH Sponsored CTSA Program
AF1 Thinking scientifically
STRATEGIC ACTION IN HEALTH (AES)
Approach: The Cuban Regulatory Strategy
Presentation transcript:

Iván D Vélez MD PhD

Malaria

ROL OF INVESTIGATORS  Politicians,  Health authorities  Pharmaceutical industry  Pipeline and deliver products for Tropical diseases multidisciplinary approach : biological, social and health sciences working together CIDEPRO: Public-Private alliance

No high indicators of research…. Papers, patents… but capacity … interest in scientist … The “ spirit” of CIDEPRO: Social use of product development Industry: no big profit but no lost … Patents as indicator of success… credibility… ???? rethinking Colombian reality

 Scientific committee  I+D+I Committee

Source of fundings  National department of science and technology  Universities  International sponsors

Help to solve problems: Thermotherapy for CL…..New, cheaper devise Local treatments for CL…… clinical evaluation of new compounds Artemisa annua infusion: international collaborative project with Luxembourg Mollusquicide for Fasciola hepatica control Generic antimalarials produced at the University drugs plants for Humaxph… cheaper Innovation

The international standards for preclinical and clinical phases : expensive We need develop capacity in some preclinical areas: toxicity in animal models… PROBLEMS

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.